Micro-TESE for Azoospermia: When a Repeat Attempt May Still Be Reasonable

Medically reviewed on 10 April 2026 - Dr. Senai Aksoy
Micro-TESE for Azoospermia: When a Repeat Attempt May Still Be Reasonable

Key Takeaways

Micro-TESE is the preferred sperm retrieval approach for many men with nonobstructive azoospermia because it can find sperm while limiting unnecessary tissue removal. If a first procedure does not find sperm, a repeat attempt may still be reasonable in selected patients after a full hormonal, genetic, and surgical review.

Micro-TESE for Azoospermia

Having no sperm in the ejaculate does not automatically rule out biological fatherhood. In nonobstructive azoospermia, sperm production may still be present in small areas of the testis, and micro-TESE is designed to locate those areas under the microscope. Even after an unsuccessful first attempt, a carefully selected repeat procedure can still lead to sperm retrieval in some patients.

Understanding Azoospermia

Azoospermia means no sperm are seen in the semen sample. It affects about 1% of men overall and a much larger share of men being evaluated for infertility. The first step is to determine whether the problem is:

This distinction matters because treatment planning, surgery, and prognosis are different in each group.

What Micro-TESE Does

Micro-TESE stands for microsurgical testicular sperm extraction. During the procedure, the surgeon opens the testis and uses an operating microscope to identify seminiferous tubules that appear more likely to contain sperm. Compared with conventional TESE, this approach is more targeted and usually removes less tissue.

In men with NOA, micro-TESE is widely considered the preferred retrieval method because it improves the chance of finding sperm while reducing unnecessary tissue loss.

Why a Second Attempt May Still Help

An unsuccessful first micro-TESE is disappointing, but it does not always end the discussion. Repeat micro-TESE can still retrieve sperm in a subset of patients, especially when the first procedure was done before the full evaluation was complete, when pathology suggests residual spermatogenesis, or when the second procedure is done in an experienced center.

Published studies suggest that repeat retrieval rates vary widely based on the patient’s diagnosis and prior findings. Patients with hypospermatogenesis or some men with Klinefelter syndrome may still have a meaningful chance of success, while complete AZFa or AZFb deletions are associated with a very poor prognosis.

Factors That Influence Success

How Patients Should Prepare

Before a repeat micro-TESE is planned, the evaluation should be revisited. That usually includes:

  1. Hormonal review to check testosterone and gonadotropins
  2. Genetic testing when indicated, including karyotype and Y-chromosome microdeletion analysis
  3. Review of previous pathology and operative details
  4. Discussion of cryopreservation if sperm are found

Realistic counseling about success rates and next steps

FAQ

Does azoospermia always mean sperm cannot be found?

No. In obstructive azoospermia, sperm production may be normal but blocked. In nonobstructive azoospermia, sperm may still be present in small areas of the testis even when none appear in the semen.

When is a repeat micro-TESE worth discussing?

A repeat attempt is usually considered only after reviewing the first surgery, the pathology, hormone results, and genetic testing. It makes more sense when there are signs that some sperm production may still be present.

Why does center experience matter so much?

Micro-TESE is a highly specialized microsurgical procedure. Outcomes depend not only on diagnosis, but also on how carefully the testis is explored and how closely the surgical and embryology teams work together.

Sources

Dr. Senai Aksoy

Dr. Senai Aksoy studied and trained in France before returning to Turkey, where he was a founding member of the ICSI team at Sevgi Hospital, Ankara — the country's first ICSI centre (1994-95) — and a co-author on the first Turkish ICSI publications produced in collaboration with the Brussels Van Steirteghem group (Human Reproduction, 1996; PMID 8671323). He helped build the IVF programme at the American Hospital Istanbul and has been running his own fertility practice since 1998.

Verified profiles: PubMed ORCID LinkedIn

The content has been created by Dr. Senai Aksoy and medically approved.